FDA Oncology Announcements

Multikinase inhibitor × Endocrine × Clear all

3 Announcements

Lenvatinib in combination with Everolimus

Drugs: Lenvima (lenvatinib) · Multikinase inhibitor, everolimus · MTOR inhibitor
Conditions: EndocrineGenitourinary

Lenvatinib (Lenvima)

Drug: Lenvima (lenvatinib) · Multikinase inhibitor
Condition: Endocrine

Vandetanib

Drug: Vandetanib Tablets (vandetanib) · Multikinase inhibitor
Condition: Endocrine